2,4-戊二烯腈,3-甲基-5-(2,6,6-三甲基-1-环己烯-1-基)- | 19834-52-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 中文名称: 2,4-戊二烯腈,3-甲基-5-(2,6,6-三甲基-1-环己烯-1-基)-
• 英文名称: 3-Methyl-1-(2,6,6-trimethyl-cyclohexen-(1)-yl)-pentadien-(1,3)-saeure-(5)-nitril
• 英文别名: β-Jonyliden-acetonitril；3-Methyl-5-(2,6,6-trimethylcyclohexen-1-yl)penta-2,4-dienenitrile
• CAS: 19834-52-7
• 化学式: C₁₅H₂₁N
• 分子量: 215.338
• InChiKey: YOYODHNOTKUUDY-UHFFFAOYSA-N

物化性质

• 沸点：
  117-122 °C(Press: 1 Torr)
• 密度：
  0.9635 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2,4-戊二烯腈,3-甲基-5-(2,6,6-三甲基-1-环己烯-1-基)- 在 哌啶 、 吡啶 、 potassium tert-butylate 、 二异丁基氢化铝 作用下， 以 甲醇 、 甲苯 为溶剂， 反应 6.0h， 生成 3,7-Dimethyl-1-(2,6,6-trimethyl-cyclohexen-1-yl)-nonatetraen-1,3,5,7-saeure-9-nitril
  参考文献：
  名称：

  [EN] COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS
  [FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE TROUBLES OCULAIRES

  摘要：

  公开号：

  WO2016085939A3
• 作为产物：
  描述：

  (EZ)-β-紫罗兰酮 、 氰乙酸 在 哌啶 作用下， 以 苯 为溶剂， 反应 18.0h， 以86%的产率得到2,4-戊二烯腈,3-甲基-5-(2,6,6-三甲基-1-环己烯-1-基)-
  参考文献：
  名称：

  [EN] COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS
  [FR] COMPOSÉS ET MÉTHODES DE TRAITEMENT DE TROUBLES OCULAIRES

  摘要：

  公开号：

  WO2016085939A3

文献信息

• Substituted Cyclohexadienals - Syntheses and Applications
  申请人：Watanabe Coran M. H.

  公开号：US20070232813A1

  公开（公告）日：2007-10-04

  The present invention is generally directed to the use of L-proline and certain derivatives thereof to catalyze the asymmetric self-condensation of α,β-unsaturated aldehydes to form homodimer and heterodimer cyclohexadienals. Reaction conditions are mild and yet amenable to a variety of different substrates yielding molecules with complex scaffolds from simple precursors. This approach allows for diversification and synthesis of this structural class of compounds in sufficient quantity, purity and enantioselectivity for, e.g., biological investigations and use as fluorescent probes, anti-cancer agents, anti-bacterial agents, and/or anti-fungal agents. The present invention is also generally directed to the cyclohexadienals produced.

  本发明通常涉及利用L-脯氨酸及其某些衍生物催化α,β-不饱和醛进行不对称自缩合，形成同二聚体和杂二聚体环己二烯醛。反应条件温和，且适用于多种不同的底物，从简单的原料生成具有复杂支架的分子。这种方法允许以足够的数量、纯度和对映选择性多样化合成这类结构的化合物，例如用于生物学研究以及作为荧光探针、抗癌剂、抗菌剂和/或抗真菌剂。本发明还一般涉及所生产的环己二烯醛。
• METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES
  申请人：Toone Eric

  公开号：US20100266621A1

  公开（公告）日：2010-10-21

  Psoralen compounds of Formula (I): wherein (N + Aryl) is a member selected from the group consisting of nitrogen containing aromatic heterocycles of formulae (i)-(iii): wherein Z is a group of formula: wherein R is C 1 -C 30 hydrocarbyl, which may be linear, branched or cyclic and contains from 1 to 15 carbon-carbon double bonds, which may be conjugated or unconjugated with one another or may include an aryl ring, and may contain one or more substituents; R 1 is hydrogen, aryl, heteroaryl, alkyl, cycloalkyl, heterocyclyl, alkenyl, alkynyl, alkene-aryl, alkene-heteroaryl, alkene-heterocyclyl, alkene-cycloalkyl, fused cycloalkylaryl, fused cycloalkylheteroaryl, fused heterocyclylaryl, fused heterocyclyheteroaryl, alkylene-fused cycloalkylaryl, alkylene-fused cycloalkylheteroaryl, alkylene-fused heterocyclylaryl, alkylene-fused heterocyclyheteroaryl; n is an integer from 1 to 8 and X is a pharmaceutically acceptable counter ion; and their use in methods for the treatment of a cell proliferation disorder in a subject, pharmaceutical compositions containing the psoralen derivatives, a kit for performing the method, and a method for causing an autovaccine effect in a subject using the method.

  公式（I）的植酸化合物：其中（N+Aryl）是从以下化学式（i）-（iii）组成的含氮芳香杂环中选择的成员：其中Z是以下化学式的一组：其中R是C1-C30烃基，可以是直链、支链或环状，并且含有1至15个碳-碳双键，这些双键可以共轭或非共轭地彼此连接，也可以包括芳香环，并且可能含有一个或多个取代基；R1是氢、芳基、杂环芳基、烷基、环烷基、杂环烷基、烯基、炔基、烯基芳基、烯基杂环芳基、烯基杂环烷基、烯基环烷基、融合环烷基芳基、融合环烷基杂环芳基、融合杂环烷基芳基、融合杂环烷基杂环芳基、烷基-融合环烷基芳基、烷基-融合环烷基杂环芳基、烷基-融合杂环烷基芳基、烷基-融合杂环烷基杂环芳基；n是1至8的整数，X是药用可接受的对离子；以及它们在治疗受体内细胞增殖紊乱的方法中的使用，含有植酸衍生物的药物组合物，用于执行该方法的工具包，以及利用该方法在受体中引起自身疫苗效应的方法。
• Process for Synthesis of (3R,3'R,6'R)-Lutein and its Stereoisomers
  申请人：Khachik Frederick

  公开号：US20090264681A1

  公开（公告）日：2009-10-22

  (3R,3′R,6′R)-Lutein and (3R,3′R)-zeaxanthin are two dietary carotenoids that are present in most fruits and vegetables commonly consumed in the US. These carotenoids accumulate in the human plasma, major organs, and ocular tissues. In the past decade, numerous epidemiological and experimental studies have shown that lutein and zeaxanthin play an important role in the prevention of age-related macular degeneration (AMD) that is the leading cause of blindness in the U.S. and Western World. The invention provides a process for the synthesis of (3R,3′R,6′R)-lutein and its stereoisomers from commercially available (rac)-α-ionone by a C 15 +C 10 +C 15 coupling strategy. In addition, the present invention also provides access to the precursors of optically active carotenoids with 3-hydroxy-ε-end group that are otherwise difficult to synthesize. The process developed for the synthesis of lutein and its stereoisomers is straightforward and has potential for commercialization.

  (3R,3′R,6′R)-叶黄素和(3R,3′R)-玉米黄质是两种膳食类胡萝卜素，在美国常见的大多数水果和蔬菜中都存在。这些类胡萝卜素在人体血浆、主要器官和眼部组织中积累。在过去的十年里，许多流行病学和实验研究表明，叶黄素和玉米黄质在预防年龄相关性黄斑变性（AMD）中发挥重要作用，这是美国和西方世界的主要致盲原因。本发明提供了一种从商业上可获得的（rac）-α-离子酮通过C15+C10+C15偶联策略合成(3R,3′R,6′R)-叶黄素及其立体异构体的方法。此外，本发明还提供了一种获得具有3-羟基-ε端基的光学活性类胡萝卜素前体的方法，这些前体在其他情况下难以合成。开发用于合成叶黄素及其立体异构体的工艺是简单明了的，并具有商业化的潜力。
• US8383836B2
  申请人：——

  公开号：US8383836B2

  公开（公告）日：2013-02-26
• US8791275B2
  申请人：——

  公开号：US8791275B2

  公开（公告）日：2014-07-29